President Donald Trump looks on after a man fainted during an announcement about weight-loss drugs in the Oval Office of the White House on Nov. 6, 2025. Andrew Caballero-Reynolds/AFP via Getty Images
A man fainted in the Oval Office on Nov. 6 as the Trump administration announced sweeping price cuts to popular GLP-1 weight loss drugs, such as Ozempic and Wegovy, starting in early 2026.
Eli Lilly CEO David A. Ricks was speaking about the deal when an unidentified man behind him, wearing a black suit, white shirt, and gray tie, started to sway back and forth.
